The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001754.5(RUNX1):c.*3582G>A

CA320248519

897095 (ClinVar)

Gene: RUNX1
Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: f14f73c9-6307-4da8-ad3a-b26122d16ba7
Approved on: 2025-01-15
Published on: 2025-01-15

HGVS expressions

NM_001754.5:c.*3582G>A
NM_001754.5(RUNX1):c.*3582G>A
NC_000021.9:g.34788553C>T
CM000683.2:g.34788553C>T
NC_000021.8:g.36160850C>T
CM000683.1:g.36160850C>T
NC_000021.7:g.35082720C>T
NG_011402.2:g.1201159G>A
ENST00000675419.1:c.*3582G>A
ENST00000300305.7:c.*3582G>A
ENST00000344691.8:c.*3582G>A
ENST00000437180.5:c.*3582G>A
NM_001001890.2:c.*3582G>A
NM_001754.4:c.*3582G>A
NM_001001890.3:c.*3582G>A
More

Likely Benign

Met criteria codes 1
BS1
Not Met criteria codes 11
BP3 BP4 BP1 BP7 BP5 PP4 PP3 PP2 PM1 PM3 BS2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Myeloid Malignancy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Myeloid Malignancy VCEP
NM_001754.5(RUNX1):c.*3582G>A is a 3' UTR variant, which has an MAF of 0.01297 (0.1297%, 23/17732 alleles) in the Admixed American subpopulation of the gnomAD v4.1.0 cohort is between 0.00015 (0.015%) and 0.0015 (0.15%) (BS1). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BS1.
Met criteria codes
BS1
gnomAD v4.1.0 23/17732 alleles in Admixed American, MAF 0.1297% All: 38/232420 alleles, MAF 0.01635% MAF of 0.01297 (0.1297%, 23/17732 alleles) in the Admixed American subpopulation of the gnomAD v4.1.0 cohort is between 0.00015 (0.015%) and 0.0015 (0.15%) (BS1).
Not Met criteria codes
BP3
This rule is not applicable for MM-VCEP
BP4
UTR variant
BP1
This rule is not applicable for MM-VCEP
BP7
UTR variant
BP5
This rule is not applicable for MM-VCEP
PP4
This rule is not applicable for MM-VCEP
PP3
UTR variant
PP2
This rule is not applicable for MM-VCEP
PM1
This variant is not a missense variant.
PM3
This rule is not applicable for MM-VCEP
BS2
This rule is not applicable for MM-VCEP
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.